Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs
1. BGI Research, Shenzhen, China
2. Department of Biology, Laboratory of Genomics and Molecular Biomedicine, University of Copenhagen, Copenhagen, Denmark
3. Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4. Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
5. Department of Endocrinology and Metabolism, Shenzhen People’s Hospital, Shenzhen, China
6. Shenzhen Key Laboratory of Unknown Pathogen Identification, BGI Research, Shenzhen, China
7. Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI Research, Shenzhen, China
kk@bio.ku.dk
Wqingw61@163.com
guyanyun@sjtu.edu.cn
zhonghuanzi@genomics.cn
Show less